Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
 Comments
Keywords:   any keywords all keywords
Comments By:     Select Commentator
Posted Date:   From
  To    
Sort By:  
   
 
  * Comments posted before 22 May 2002 cannot be searched or sorted by posted date. Enter keywords and/or commentator and click this button to search only these comments.
Search Results: Comments By= Mufson, Elliott; Sort By= Posted Date
1 to 30 of 71 results
Mufson E. on PAPER: Deane R. et al., 2012, This most interesting paper presents a well-designed set of experiments, which provide evidence... 12 Apr 2012. 

Mufson E. on PAPER: Sperling RA. et al., 2011, Sperling and colleagues suggest that brain amyloid deposition drives the clinical sequelae... 13 Dec 2011. 

Mufson E, Overk C. on NEWS: Hormone Replacement Therapy Latest Entry to AlzRisk Database, While hormone therapy is the most effective treatment for vasomotor symptoms associated with... 4 Nov 2011. 

Mufson E. on NEWS: Anti-Aβ Oligomer Headed for Phase 3 Clinical Trial, These types of press releases and hyped reviews only give false hope to the public. The AD... 1 Sep 2010. 

Mufson E. on PAPER: Decker H. et al., 2010, This is an interesting and well-presented study, but as with many studies of Aβ toxicity, the... 22 Jul 2010. 

Mufson E. on PAPER: de Calignon A. et al., 2010, The findings of Alix de Calignon and colleagues are interesting and support several studies... 15 Apr 2010. 

Counts S, Mufson E. on PAPER: Rohe M. et al., 2009, The article by Rohe and colleagues presents data derived from in vivo and in vitro studies... 21 Dec 2009. 

Mufson E. on NEWS: Paper Alert-cum-SfN: Bapineuzumab Published, More AN1792 Presented, This may be a naive question, but if amyloid deposition in the brain is a critical factor in... 1 Dec 2009. 

Mufson E. on PAPER: Sotthibundhu A. et al., 2008, Recommendation Only. 2 Jul 2009. 

Mufson E. on PAPER: Soscia SJ. et al., 2010, This interesting concept could begin to explain the widespread amyloid response in AD and in... 7 Apr 2009. 

Ginsberg S, Mufson E. on NEWS: AD Clinical Pipeline: Immunotherapy Woes, Dimebon Boons, This paper is a jarring wake-up call to all Alzheimer disease investigators that placed all... 8 Aug 2008. 

Mufson E. on PAPER: Jang SW. et al., 2007, The neurotrophin nerve growth factor (NGF) and its high-affinity receptor TrkA play a major role... 5 Oct 2007. 

Mufson E. on NEWS: eFAD Research Surprise: In Mutation Carriers, Amyloid Starts in Striatum, The work by Klunk and coworkers (2007) demonstrates how incomplete our understanding is of the... 21 Jun 2007. 

Mufson E. on NEWS: Salzburg Overview: 8th International Conference Draws Record Number, I was a speaker at the AD/PD meeting in Salzburg. My congratulations go out to the organizers of... 2 Apr 2007. 

Mufson E. on PAPER: Dorsey SG. et al., 2006, The articles by Dorsey and colleagues and Mobley's group (see Salehi et al., 2006) are... 8 Dec 2006. 

Mufson E. on NEWS: Looking outside the Brain for Early Signs of AD, The search for a biomarker that distinguishes AD from other neurological dementias is a fertile... 4 Oct 2005. 

Mufson E. on PAPER: Rösch H. et al., 2005, Rosch and colleagues in the May 17 issue of PNAS provide intriguing new data implicating p75NTR... 29 Jun 2005. 

Mufson E. on PAPER: Andorfer C. et al., 2005, This is a most interesting and provocative study. It adds yet another wrinkle to the AD... 20 Jun 2005. 

Mufson E. on NEWS: Huntingtin, BDNF, Neurodegeneration: Is Speed of the Essence?, The findings of decreased BDNF transport in Huntington's disease, as well as the reports by the... 27 Jul 2004. 

Mufson E. on PAPER: Takashima S. et al., 1997, Good review.  No date saved. 

Mufson E. on PAPER: Kim TW. et al., 1997, Interesting No date saved. 

Mufson E. on PAPER: Lopez-Alberola RF. et al., 1997, Interesting No date saved. 

Mufson E. on PAPER: Kamboh MI. et al., 1997, Interesting No date saved. 

Mufson E. on PAPER: Samuel W. et al., 1997, Interesting study.  No date saved. 

Mufson E. on PAPER: Vincent I. et al., 1997, Interesting. No date saved. 

Mufson E. on PAPER: Hibbard LS. et al., 1997, Noteworthy.  No date saved. 

Mufson E. on PAPER: Guo Q. et al., 1996, Interesting No date saved. 

Mufson E. on PAPER: Lopez OL. et al., 1997, Interesting No date saved. 

Mufson E. on PAPER: Jicha GA. et al., 1997, Noteworthy.  No date saved. 

Mufson E. on PAPER: Beard CM. et al., 1997, Interesting No date saved. 

1 to 30 of 71 results
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ALS Forum

The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
ALS Forum
Polls
 
Should the FDA be allowed to use data from overseas clinical trials?

Absolutely, we are running out of viable subjects in the U.S.
 9
 
Yes, so long as the data is reliable
 31
 
No, the trials are not as rigorous
 3
 
No, the data should be repeated in the U.S.
 5
 
No, the drug sponsors are just trying to cut corners
 3
 
Responses: 51
 
 
 
 
 
Archived Polls
 
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Forum Calendar

Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad